244 related articles for article (PubMed ID: 10585606)
1. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
[TBL] [Abstract][Full Text] [Related]
2. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.
Iwanuma Y; Chen FA; Egilmez NK; Takita H; Bankert RB
Cancer Res; 1997 Jul; 57(14):2937-42. PubMed ID: 9230205
[TBL] [Abstract][Full Text] [Related]
3. Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model.
Egilmez NK; Jong YS; Hess SD; Jacob JS; Mathiowitz E; Bankert RB
J Immunother; 2000; 23(2):190-5. PubMed ID: 10746545
[TBL] [Abstract][Full Text] [Related]
4. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
Hess SD; Egilmez NK; Shiroko J; Bankert RB
Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457
[TBL] [Abstract][Full Text] [Related]
5. Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model.
Egilmez NK; Jong YS; Iwanuma Y; Jacob JS; Santos CA; Chen FA; Mathiowitz E; Bankert RB
Cancer Immunol Immunother; 1998 Mar; 46(1):21-4. PubMed ID: 9520288
[TBL] [Abstract][Full Text] [Related]
6. Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma.
Hess SD; Egilmez NK; Bailey N; Anderson TM; Mathiowitz E; Bernstein SH; Bankert RB
J Immunol; 2003 Jan; 170(1):400-12. PubMed ID: 12496425
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
8. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
Sabel MS; Su G; Griffith KA; Chang AE
Breast Cancer Res Treat; 2010 Jul; 122(2):325-36. PubMed ID: 19802695
[TBL] [Abstract][Full Text] [Related]
10. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma.
Li D; Shugert E; Guo M; Bishop JS; O'Malley BW
Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
12. The SCID mouse reaction to human peripheral blood mononuclear leukocyte engraftment. Neutrophil recruitment induced expression of a wide spectrum of murine cytokines and mouse leukopoiesis, including thymic differentiation.
Santini SM; Rizza P; Logozzi MA; Sestili P; Gherardi G; Lande R; Lapenta C; Belardelli F; Fais S
Transplantation; 1995 Dec; 60(11):1306-14. PubMed ID: 8525526
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
14. Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.
Broderick L; Yokota SJ; Reineke J; Mathiowitz E; Stewart CC; Barcos M; Kelleher RJ; Bankert RB
J Immunol; 2005 Jan; 174(2):898-906. PubMed ID: 15634912
[TBL] [Abstract][Full Text] [Related]
15. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
16. Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors.
Nair RE; Kilinc MO; Jones SA; Egilmez NK
J Immunol; 2006 Jun; 176(12):7325-34. PubMed ID: 16751376
[TBL] [Abstract][Full Text] [Related]
17. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
18. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
[TBL] [Abstract][Full Text] [Related]
19. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
20. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice.
Sun R; Zhang J; Zhang C; Zhang J; Liang S; Sun A; Wang J; Tian Z
Cell Mol Immunol; 2004 Apr; 1(2):129-36. PubMed ID: 16212900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
